CURRICULUM VITAE March 30 , 2010 Dana Oliver, M.P.H.

, MT(ASCP), PhD candidate

Home Address: s, Mo, 63110

2626 Gurney Court St. Loui Phone: 3

14-773-2868 Cell: 31 4-750-2135 Email: d oa13ec2@westpost.net The following CV will indicate my experience and abilities in Quality assurance, performance and compliance analyzing and reporting. In addition I provide how t o conduct Quality Assurance and Performance Reports for abstracts to medical res idents. I also teach research study design and biostatistical summaries to medic al students, residents, fellows and faculty, while providing support in these ar eas. I have considerable experience as a teacher of biostatistics in the SLU gra duate program, for the School of Nursing. Additionally I have been a guest lectu rer in the universityas School of Allied Health, and in industry settings (e.g., in Japan where I was a guest lecturer for Sysmex Corp.). I also created and pre sented a seminar series for validation of new laboratory devices. I have worked with various statistical software packages (e.g., SPSS and SAS) and developed a nd managed a large database. I have done extensive clinical trial work as well ( see attached list). Finally, I am involved in community outreach, having develop ed and implemented an anti-cancer campaign and program for high school students (many of whom were active participants). PROFESSIONAL AND Educational Background Currently a student in the PhD program at Saint Louis University: Saint Louis U niversity, St. Louis (Anticipated graduation spring semester 2011) MPH 2002 Community Health Concentration: Biostatistics Internship Practical Experience Project: Statis tically summarize outcomes when using Umbilical Cord Blood as a first -line trea tment of various types of cancers in children < 12 years of age. Cardinal Glenno n Childrenas Hospital. Submitted to the FDA. BS 1990 Clinical Laboratory Science PROFESSIONAL CERTIFICATION MT (ASCP) # 03006518 1990 PROFESSIONAL EXPERIENCE Saint Louis University School of Allied Health Saint Louis University School of Public Health

1/02 a" 6/10 Louis

Biostatistician Co-director, Tissue Biorepository Quality Assurance/Improvement Coordinator-Saint University Cancer Center

Saint Louis University Cancer Center Responsibilities include: - Provide support for purpose of generating publications, grant and IRB protocol submissions and quality improvement reports in the cancer setting. - Preparation of data for FDA submissions of (1) new clinical hematology lab ins trumentation, and (2) annual outcome reports - Outcomes research (survival and recovery) of patients diagnosed and treated wi th hematopoietic stem cell transplant, stereotactic radiosurgery, radiation and chemotherapy. - Provide statistical support and design for grants, protocols and outcome analy sis of research studies. - Develop standardized and customizable data collection forms and databases for various clinical research protocols. Tissue Biorepository (Co-director): - Write protocols, - Monitor quality control, - Validate new lab methods, - Cryopreserve tissues for future research studies focused on the identification of biomarkers for early diagnosis of cancer Adjunct faculty/instructor of Statistics (Saint Louis University): 1.) School of Health Sciences doctoral program: Nurs 625 ANOVA and Experimental Design (Taught course using different platforms: Traditional Classroom, Live Web-based and E-classroom at the students own pace.) 2.) School of Professional Studies (Informatics program): CST 295 Principles of Data Analysis 3.) Dept of Research Methodology (Graduate School): RM530, Applied Regression Models RM625,Analysis of Variance Provide Continuing Education Statistical Seminars to faculty, fellows, reside nts medical students, research assistants and undergraduate interns in Nuclear M edicine Technology, Occupational Therapy and Dietary programs 1.) Statistical analysis and the importance of data entry: Topics include: - Issues to consider before choosing the appropriat e statistical method - Parametric and their non-parametric alternatives required for small sample size (pilot study data to be used for the gen eration of sample sizes for future studies requiring approximatel y 80% power) experiments in the basic science setting - Survival analysis - Mutivariate analysis - Statistics for microarray experiments 2.) sign the 3.) Critical review of medical literature focusing on appropriateness of the de and statistical methods utilized for the purpose of the clinician to chose most appropriate standard of care. Clinical Trial design: Hematology a" Oncology Fellows Program

Nuclear Medicine Residents and Technologi sts Dermatology Residents Radiation Medicine Emergency Medicine Orthopaedics Ophthalmology School of Allied Health undergraduate int erns (Nuclear Medicine technologists, Occupati onal Therapists) Consultant: - Assist School of Nursing and School of Health Sciences faculty staff in prepa ration/design of protocols, grant submissions and outcomes analysis for publicat ions. - Provide assistance to hospital nursing staff when development and pilot testin g a new bedside method (PI: Dr. N Metheny, Saint Louis University ) Created two statistical users groups, (meets monthly), comprised of basic scient ists and clinical researchers: 1.) Analysis of data collected from gene microarray a nalysis 2.) Statistical Journal Club and Constructive Criticism of Outcome studies 6/98 a" 12/01 Senior Research Assistant / Biostatistician Pediatric Research Institute /Saint Louis University Responsibilities include: - Project coordinator for beta-site testing of new clinical laboratory equipment and methodologies; providing statistical assistance for publications, abstracts and poster presentations at meetings; - Preparation of data for FDA submissions of: (1) new clinical lab instrumentation parameter (Assessment for the addition of a screening parameter to a previously FDA approved device for enumeration of hem atopoetic progenitor cell collections from umbilical cord blood or GCSF mobilize d blood a" products to be used for future transplants- SYSMEX Corporation of Ame rica and Japan), My responsibility was two-fold for the above-mentioned project: I performed the laboratory studies as well as collected the data from the other 5 sites collabo rating on the project to determine if the screening method was reliable for pred icting a good outcome post stem cell immobilized GCSF apheresis collection and s urvival post transplant. (2) Annual outcome reports and FDA submission summarizing safety ( time to recovery, survival and recurrence or relapse outcomes and efficacy of umbilical cord blood transplants). - Monitoring of quality control and quality assurance of hematology and flow cytometric testing performed in the stem cell laboratory; evaluation and set-up of new laboratory tests to be utilized by the stem cell lab; - Data management and statistical evaluation of bone marrow and umbilical cord b lood stem cell transplants performed at Bob Costas Cancer Center at CGCH, Saint Louis Cord Blood Bank. 9/79a"6/98

Technical Specialist/Project Coordinator St. Louis University Hospital, St. Louis, Mo. - Coordination of beta site testing performed in the Hemostasis/Thrombosis lab for new - Clinical instructor for Saint Louis University Clinical Laboratory Science De partment Saint Louis University. - Coordination of training of fellows and residents in Hemostasis/Thrombosis la boratory. - Monitoring of quality control and quality assurance of testing performed by Coagulation Consultants laboratory.

PUBLICATIONS, BOOK CHAPTER, ABSTRACTS, PRESENTATIONS, POSTERS Publications: 1. Alonso JM, DM Regan, CE Johnson, DA Oliver, R Fegan, L Lasky, DA Wall. A sim ple and reliable procedure for cord blood banking processing and freezing. Cyto therapy, 2001. 2. Oliver DA, Wall DA. Use of the hematopoietic progenitor cell parameter on the Sysmex SE-9500 as a screening tool to guide the timing of the leukapheresis in the pediatric setting. Infusion Therapy and Transfusion Medicine. 2001;28:267-2 70. 3. HS Goodwin, AR Bicknese, S-N. Chien, BD Bogucki, DA Oliver, DA Wall. Multilin eage differentiation activity by cells isolated from umbilical cord blood into c ells expressing bone, fat and neural markers. Biology of Blood and Marrow Transp lantation. Sept. 2001 4. Fu-Sheng Wang, Takashi Morikawa, Seido Biwa, Dana Oliver, Michael Creer, Yuki o Hamaguchi, Kojiro Hirai. Monitoring hematopoietic stem and progenitor cells w ith Sysmex automated hematology analyzers. Laboratory Hematology, 2002, 8:119-1 25. 5. HD Goodwin, LM Grunzinger, DM Regan, KA McCormick, CE Johnson, DA Oliver, KA Mueckl, JM Alonso, and DA Wall. Umbilical Cord Blood unit contiguous segment co nfirms identity and hematopoietic potential. Accepted for publication in Cytoth erapy 2003. 6. Dana Oliver, Suzanne M. Mahon. Reading a research article. Part I: Types of v ariables. Clinical Journal of Oncology Nursing, 2005, 9/1. 7. Brent A. Neuschwander-Tetri, Elizabeth M. Brunt, Kent R. Wehmeier, Dana Olive r and Bruce R. Bacon. Improved nonalcoholic steatohepatitis after 48 weeks of tr eatment with PPAR- Ligand Rosiglitazone. Hepatology 2003. 8. Elizabeth M. Brunt, Brent A. Neuschwander-Tetri, Dana Oliver, Kent R. Wehmeie r, and Bruce R. Bacon. Nonalcoholic steatohepatitis: Histologic features and cli nical correlations with 30 blinded biopsy specimens. Human Pathology, September 2004. 9. Dana Oliver, Suzanne M. Mahon. Reading a research article. Part II: Parametri c and nonparametric statistics. Clinical Journal of Oncology Nursing, 2005. 10. Norma A. Metheny, Jena Stewart, Gretel Nuetzel, Dana Oliver, Ray E. Clouse. Effect of feeding-tube properties on residual volume measurements in tube-fed p atients patients. Journal of Parenteral and Enteral Nutrition, vol 29, No.3, 20 05, 192-197

11. Yi Pan, Haibo Zhang, Aninda B. Acharya, Ping H. Patrick, Dana Oliver, John E . Morley. Effect of testosterone on functional recovery in a castrate male rat stroke model. Brain Research 1043 (2005) 195-204. 12. e Data Dana Oliver, Suzanne M. Mahon. Reading a research article. Part III: Th collection instrument: Survey Tools. Clinical Journal of Oncology Nur sing, 2006. 13. inical practice. The results Society member survey. Head and Neck 14. A. November 2005 Norma A. Metheny, PhD; Ray E. Clause,MD; Barbara J. Stewart, PhD, Dana Oliver,MPH; Marin Kollef,MF. Tracheobronchial aspiration of gastric c ontents in Medicine, Aril 2006, Volume 34, Issue 4. 15. for identifying patients without advanced disease. GUT 2008;57:1441-144 7. April 2008. 16. al of Systemics Cybernetics and Informatics, Submitted for publication.. 17. NC Nguyen, IE Akdumen, MM Sayed, D Oliver, MM Osman. Increased F-18 FDG uptake in the posterior ocular bulb is associated with brain meta stasis: A retrospective study. AJR, in preparation for publication November 20 08. Book Chapter: Osman, Medhat M., Oliver, Dana A., et al. Chapter 5 FDG-PET/CT for treatment Pl anning and Follow-Up. Robotic Radiosurgery: Treating Tumors that Move with Res piration. Urschel H. C., Ed., et al. Springer-Verlag Berlin Heidelberg, 2007. Abstracts: 1. Oliver DA, JM Alonso, N Gould, RJ Fallon, DA Wall. Comparison of hematopoiet ic progenitor cell (HPC) parameter as measured by SYSMEX9500 with CD34 and CFU a ssays for the purpose of rapid assessment of circulating progenitors. ASH 1998. 2. Oliver DA, S-N Chien, JM Alonzo, DM Regan, CE Johnson, DA Wall. An Approach to Assigning Hematopoietic Potential to Umbilical Cord Blood Products: Limitatio n with Use of a Single Measure of Hematopoiesis. International Society for Hema totherapy and Graft Engineering, Oslo, June 1999. (oral presentation). 3. Oliver DA, JM Alonso III, N Gould, RJ Fallon, DA Wall. Correlation of Hemato Dana Oliver, MPH, James Hardin, PhD, John Buerck, PhD. Applying medic informatics to support evidence-based medicine. Submitted to Journal S A Harrison, D Oliver, H L Arnold, S Gogia, B A Neuschwander-Tetri. Development and validation of a simple NAFLD clinical scoring system of an international American Head and Neck Jeremy D. Meier, MD, Dana A. Oliver, MPH, Mark A. Varvares, MD, FACS. Surgical margin determination in head and neck oncology: current cl

poietic Progenitor Cell (HPC) Parameter as measured by Sysmex 9500 with CD34 and CFU assays on Cord Blood - Implications for Banking. International Society for Hematotherapy and Graft Engineering, Oslo, June 1999. 4. Wall DA, DA Oliver, G Gale, RJ Fallon. Use of the hematopoietic progenitor c ell (HPC) parameter of the Sysmex SE9500 to monitor stem cell pheresis. Blood 94 : Supplement 1(part 2), page 140a. 1999. 5. Oliver D, Alonso JM, Gould N, Fallon RJ, Wall DA. Correlation of hematopoiet ic progenitor cell parameter as measured by Sysmex 9500 with CD34 and Colony F orming Unit assays on cord blood- Implication for banking. ISHAGE meeting-poste r presentation, Oslo, Norway,1999. 6. Oliver DA, CE Johnson, KA Hofmeister, SJ Schwartz, CA Toczylowski, DA Wall. Correlation of cord blood nucleated red cell count (Sysmex XE2100) a nd CD34+ cell quantitation: Implications for cord blood banking. Internatio nal Society of Laboratory Hematology 2000 meeting. Abstract and oral presentation . 7. e Budge D, DA Oliver, KA Wassmer, MF Steffen, RJ Fallon, DA Wall. Immun

reconstitution following unrelated donor cord blood transplantation. International Societyfor Hematotherapy and Graft Engineering, San Diego, June 2000, Oral presentation. 8. Johnson CE, DB Newby, DM Regan, K Acton, DA Oliver, E Swierkosz, DA Wall. Optimal bacterial contamination monitoring for cord blood b anking: A quality control trial. AABB fall 2000 meeting, poster presentation . 9. Goodwin HS, DM Regan, DA Oliver, JMF Alonso III, DA Wall. Assessment of cord blood product viability for application in cord blood banking and transplantat ion. AABB fall 2000 meeting, poster presentation. 10. Wall DA, DA Oliver, DM Regan, MJ Alonso, KM Wassmer, DL Budge, RJ Fallon Th resholds for reliable neutrophil recovery following unrelated donor cord blood transplant: relative impact of total nucleated cells (TNC), CD34, and CFU dose. Submitted American Society of Hematology December 2000 meeting. Poster presentation. 11. Wall DA, M Swanston, K Mueckl, H S Goodwin, JL Chu, CE Johnson, DA Oliver. Correlation of cord blood CD34 count and nucleated red cell count: both are increased after stressful labor. American Society of Hematolog y December 2000 ting. 12. Regan DM, MJ Alonso, CE Johnson, DA Oliver, DA Wall. Utilization of cor d blood banking inventory: Impact of banking practices. ISHAGE meeting 2001, Queb ec City Quebec. 13. John M. Richart, Paul J Petruska, Kathleen S Klebert, Bruce R Harrison, Ter esa

L Dunleavy, Dana A Oliver, H Joachim Reimers, John L Visconti, Steven M Pincus, Frank R Dunphy A Phase III trial of Epoetin-alfa: early vs l ate administration in 02. 14. Gautam K Singh, Cytnia Marino, Dana Oliver, Ian Balfour, Su-Chung Chen, Saadeh Jureidini, P Syamasundor Rao. Pressure gradients in outflow stenotic lesions: A simultaneous Doppler and catheter correlative study in pediatric patients. American Society of Echocardiograhy, 2000 Abstract- poster presentat ion. 15. Gautam K Singh, Cynthia Marino, Dana Oliver, Ian Balfour, Su-Chung Chen, Saadeh Jureidini, P Syamasundor Rao. Doppler pressure gradient accuracy i n obstructive cardiac lesions: A simultaneous Doppler-catheter correlative s tudy in pediatric patients. 2000 16.Gautam K Singh, Dana Oliver, Dorothy K. Grange, Ian Balfour, Su-Chung Chen, Saadeh Jureidini, P Syamasundor Rao. Aortic root morphometry and aortopulmonary complex bnormalities are independent predictors of 22q11 deletion syndrome: echocardiographic study. 2000 17.J. Beattie, G. Rivers,T. Dunleavy, D. Oliver, P. Salem, F. Dunphy; Saint Lo uis University, St. Louis, MO, Phase II study of dose-intensive docetaxel and carboplatin with G-CSF in Newly diagnosed advanced non-small-cell lung ca ncer (NSCLC). Submitted 12/2002 for ASCO 2003 meeting. 18. aint vity and time to vely as CD34 cell count. Presentation for Sysmex Corporation, Sweden, Feb 2005 meeting 19. Dana A. Oliver, John Buerck, Dorina, Kallogjeri, Kathleen Klebert, Damon Harbison, Bruce Walz, Richard Bucholz, James W. Hardin A Practical database for management of an academic Cyberknife site, Cyberknife user s group meeting, San Diego, Ca 2006 20. Chris Rimkus,MSM,AOCN, Patty Waller,OCN,Dana A. Oliver, MPH, John M. Richart,MD, and Steven M. Pincus MD,PhD. Melphalan-induced severe oral mucositis is prevented by oral cryotherapy in autologous heamotopoietic cell transplant recipients. International Society for Bone Marrow Transplant conference, Hawaii, 2006. (poster presentation) 21. Dana Oliver, Dorina Kallogjeri, Kathleen Kleibert, Damon Harbison, Keith Naunheim McDonald Logie, Bruce Walz Saint Louis University School of Medicine , Saint Louis University Hospital , Saint Louis University Can cer Center Short and Long Term Outcomes following Stereotactic Radiosurgery for tr engraftment in autologous apheresis PBSC products as effecti Dana A. Oliver, Donna M.Regan, Saridey Sal Kaumund, Michael C. Creer. S Louis University, St. Louis Mo.HPC in peripheral blood predicts CFU acti patients treated with chemotherapy. ASH abstract, 20

eatment of Lung Cancer (primary) Ca 2007, (poster presentation) 22. nd informatics Conference, Orlando, Florida, July 2007, Oral presentation 23. C. Popp, J. Buerck, D. Oliver, M. Varvares, Using an electronic data managem ent system to indentify health disparities in oncology dietetic practice. Center for Disease Control onference, Atlanta, Ga, Aug 2007 (poster presentation) Chris Rimkus, MSN 24. Dana Oliver, MPH, Medhat Osman, MD, PhD; Dorina Kallogjeri, MD,MPH, Bruce Walz,MD, Mark Varvares, MD. An ain-traininga multidisciplinary team for Customized database development to disseminate translational and evide nce based clinical practice. Advancing practice, Instruction and Innovatio n through Informatics Conference, 25. 26. DG 2008. 27. 8F FDG- PET/CT: Initial Experience. JNM 2008; 49, Suppl. 1, 146P. 28. d and edhat eutics, , Department of Radiology, Nuclear Medicine, St. Louis, MO, United State s; 3. SLU, SLU Cancer Center, St. Louis, MO, United States. 29. Contamination in 18F-FDG PET/CT: An Initial Experience Abhinandan Bains;Crys tal Botkin;Dana Oliver;Nghi Nguyen; Medhat Osman;; 1. Department of Medical Imag ing and Radiation Therapeutics, Doisy College of Health Sciences,, ; 2. Cancer C enter, St. Louis University,, ; 3. Nuclear Medicine, St. Louis University, St. L ouis, MO, United States; 4. 30. Variations in Arm Positions in FDG PET/CT Rachel Littlejohn;Crystal Botkin;D ana Oliver;Nghi Nguyen;Medhat Osman;; 1. Department of Medical Imaging and Radia Impact of head holder in reducing misregistration in the area of the hea neck on PET/CT. Chris Nation;Dana Oliver;Crystal Botkin;Nghi Nguyen; M Osman;; 1. SLU, Department of Medical Imaging & Radiation Therap Doisy College of Health Sciences, St. Louis, MO, United States; 2. SLU MH Sayed, NC Nguyen, DS Oliver, KS Naunheim, RD Bucholz, BJ Walz, MM Osman: Response to Cyberknife stereotactic radiosurgery as detected with 1 Pittsburgh, Sept 2007 (E-poster presentation) A Kaushik, MM Osman, D Oliver, M Varvares, NC Nguyen: Role of F-18 FDG PET/CT in staging of head and neck cancer. Accepted for RSNA 2008. K Taalab, T Rios, NC Nguyen, J Cummings, D Oliver, MM Osman: Utility of F PET/CT in staging and restaging of prostate Cancer. Accepted for RSNA Dana Oliver, MPH; James Hardin, PhD, John Buerck, PhD. Applying medical informatics to support evidence-based medicine. Sytemic, cybernetic a Cyberknife users group meeting, Palm Springs,

tion Therapeutics, Doisy College of Health Sciences, SLU, St. Louis, MO, United States; 2. Department of Medical Imaging and Radiation Therapeutics, Doisy Colle ge of Health Sciences, SLU, St. Louis, MO, United States; 3. SLU Cancer Center, St. Louis University, St. Louis , MO, United States; 4. Department of Radiology, Nuclear Medicine, SLU, St. Louis, MO, United States; 5. Department of Radiology , Nuclear Medicine, SLU, St. Louis, MO, United States; 31 Patterns and Prevalence of Truncation Artifacts in PET/CT Renee Habing;Dana O liver;Crystal Botkin;Medhat Osman;Nghi Nguyen;; 1. Doisy College of Health Scien ces, Department of Medical Imaging and Radiation Therapeutics, St Louis, MO, Uni ted States; 2. SLU Cancer Center, SLU, St Louis, MO, United States; 3. Departmen t of Radiology, Nuclear Medicine, St Louis, MO, United States; 32 Incidental Diagnosis of Thrombus within an Aneurysm in FDG PET/CT: Frequency in 926 Patients Razi Muzaffar;Nghi Nguyen;Medhat Osman;Hussein Farghaly;Dana Oli ver;Michael Wolverson;; 1. SLU, Dept of Radiology, Div of Nuclear Medicine, St. Louis , MO, United States; 2. Cancer Center, SLU, St. Louis, MO, United States; 3. SLU, Dept of Radiology, St. Louis , MO, United States; 33 Post-radiation changes in head & neck cancer patients: Patterns and Prevalenc e as detected by 18F-FDG PET/CT Hussein Farghaly;Ted Ling;Dana Oliver;Bruce Walz ;Mark varvares;Nghi Nguyen;Medhat Osman;; 1. SLU, Nuclear Medicine , St. Louis, MO, United States; 2. SLU, Cancer Center, St. Louis, MO, United States; 3. SLU, Radiation Oncology , St. Louis, MO, United States; 4. SLU, Otolaryngology, St. L ouis, MO, United States;

PRESENTATIONS/ SEMINAR SERIES/ USER WORKSHOPS a.) Use of the hematopoietic progenitor cell parameter on the Sysmex SE-9500 as a screening tool to guide the timing of leukapheresis. Presented at: 1. ASH meeting, 1999 2. Stem Cell Conference-St. Louis University,1999 3. Hematology Conference, New York, 1999 b.) Correlation of cord blood nucleated red cell count and CD34+ cell Quantitation. Presented at: 1. ISLH meeting- Banff Canada, 2000 2. Stem Cell Conference-St. Louis University.2000 c.) Cord Blood Transplantation, Banking and Biology Presented at: 1. St. Louis University Pediatrics Grand Rounds, 2000 2. Hematology Conference; sponsored by RocheSt. Louis d.) Laboratory evaluation of the HPC parameter Presented at: Sysmex Corporation marketing meeting-Chicago 2001 e) aUse of HPC in a Changing Environmenta Sysmex Corp marketing meeting, Kobe, Japan 2002 f.) aImproving theTransplant Process a Presented at: American Association of Clinical Chemistry meeting, Orlando, 2002 Sponsored by Sysmex Corporation

g.) aUse of Basic Statistical Analysis to Monitor Umbilical Cord Blood Products in the Progenitor Cell Transplant Settinga Clinical Research Coordinators Educational Symposium-Saint Louis University, 2002. h.) aHematopoietic Cell Performance Characteristicsa Hematology Technologists/Pathologists HPC users workshop, Chicago Il., Jan 05 i.) aHemaotopoietic Progenitor Cell Correlation Dataa Hematology Technologists/Pathologists HPC users workshop, Chicago Il., Jan 05 j.) aScreening parameters used to monitor engraftment and characterize stem cell productsa Hematology Technologists/Pathologists HPC users workshop, Chicago Il., Jan 05 k.) Applying medical informatics to support evidence-based medicine. Systemic, Cybernetic l presentation given by John Buerck Committees Missouri Cancer Consortium Saint Louis University Cancer Committee a" Biostatistician/ Quality Ass urance Performance Improvement Data Safety Monitoring Committee Internal Advisory Committee-Saint Louis University Cancer Center Stem Cell Transplant Program- Quality Assurance/Performance Improvement PROFESSIONAL ORGANIZATIONS American Statistical Association American Society of Clinical Laboratory Pathology American Mathematical Association American Association of Investigative Pathology International Society for Biological and Environment Repositories PREVIOUS COMMUNITY ACTIVITIES M Missionary work in Haiti (Assisto set set up a lab to be used as a prevention measure for sickle cell anemia Math tutor for St. Louis inner city youths wanting to obtain GED or HS diploma Proctor Tutor, Missouri School for the Blind Missionary work in Haiti (Provided assisted tot set up a lab to be used as a pr evention measure for sickle cell anemia Math tutor, East Central College PROFESSIONAL ORGANIZATIONS American Statistical Association American Society of Clinical Laboratory Pathology and informatics Conference, Orlando, Florida, July 2007, Ora

American Mathematical Association American Association of Investigative Pathology International Society for Biological and Environment Repositories Cyberknife Society